← Leaderboards
Nicholas Joseph Hand
University Of Pennsylvania
$874,764
Attributed
$1,749,527
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $480.5K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,749,527 · 1
By mechanism
R01$1,749,527 · 1
Top collaborators
- Yoseph Barash6 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- David A Mankoff$17,196,499
- Yoseph Barash$7,413,836
- Barry S. Cooperman$12,073,855
- E Bryan Crenshaw$11,052,083
- Kathryn Elizabeth Hamilton$5,760,810
Others in their field
Other Rising Stars on “Proteins”
- Suma Babu · Massachusetts General Hospital$18,972,058
- Sabrina Paganoni · Massachusetts General Hospital$18,972,058
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
- Maximilian Haeussler · University Of California Santa Cruz$12,592,563
Research focus
ProteinsProtein ExpressionInitiator CodonOutputGene ProteinsPreservationGenetic DatabasesHeritabilityMessenger RnaOpen Reading Frames5&AposClinically RelevantCodePeptidesAffectGenesGenetic DiseasesHereditary DiseaseBmpr2 GeneExhibitsDisease PhenotypeEvolutionCellsPublishing
Grant awards (6)
Identifying regulatory uORFs as a targetable axis for hereditary disease$404,023
R01 · FY2025 · GM
Identifying regulatory uORFs as a targetable axis for hereditary disease$404,023
R01 · FY2024 · GM
Identifying regulatory uORFs as a targetable axis for hereditary disease$66,558
R01 · FY2024 · GM
Identifying regulatory uORFs as a targetable axis for hereditary disease$404,023
R01 · FY2023 · GM
Identifying regulatory uORFs as a targetable axis for hereditary disease$76,447
R01 · FY2023 · GM
Identifying regulatory uORFs as a targetable axis for hereditary disease$394,453
R01 · FY2022 · GM